Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

July 31, 2014

Study Completion Date

January 31, 2015

Conditions
Enteric FeverTyphoid Fever
Interventions
DRUG

Ceftriaxone

"* ≥2-\<14 years - 60mg/kg/ once daily for 7 days~* 14 years and older - 2g once daily for 7 days~* Intravenous infusion. Vials of crystalline powder."

DRUG

Gatifloxacin

Gatifloxacin 10 mg/kg/day for 7 days. Tablets for oral administration.

Trial Locations (2)

Unknown

Civil Hospital, Kathmandu

Patan Hospital, Kathmandu

All Listed Sponsors
collaborator

University of Oxford

OTHER

collaborator

Patan Academy of Health Sciences, Nepal

UNKNOWN

collaborator

Patan Hospital, Nepal

UNKNOWN

collaborator

Civil Hospital, Nepal

UNKNOWN

lead

Oxford University Clinical Research Unit, Vietnam

OTHER

NCT01421693 - Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever | Biotech Hunter | Biotech Hunter